RHENMAN & PARTNERS ASSET MANAGEMENT AB
Q4 2023 Form 13-F
STOCKHOLM
CIK 0001599882
· Institutional investment manager
$1.0B Reported Value Total
Reported value
$1.0B
Quarter over quarter
+12.2%
Holdings
85
Top-10 concentration
34.9%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Teresa Isele
CEO
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2023 13F record
Q4 2023 13F filing summary
| Period of report | December 31, 2023 |
|---|---|
| Filed | February 13, 2024 |
| Form | 13F-HR |
| Reported value | $1.0B |
| Positions | 85 |
| Change in reported value | +7.9% |
| New positions | 15 |
| Exited positions | 15 |
| Position turnover | 30.0% |
| Top-10 concentration | 34.9% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 13, 2026
|
99 | $1.1B |
|
Q1 2026 13F
Filed May 14, 2026
|
86 | $810.5M |
|
Q4 2025 13F
Filed Feb 13, 2026
|
94 | $1.1B |
|
Q3 2025 13F
Filed Nov 13, 2025
|
92 | $903.7M |
|
Q2 2025 13F
Filed Aug 13, 2025
|
90 | $791.0M |
|
Q1 2025 13F
Filed May 14, 2025
|
94 | $870.0M |
|
Q4 2024 13F
Filed Feb 13, 2025
|
92 | $972.9M |
|
Q3 2024 13F
Filed Nov 13, 2024
|
95 | $1.2B |
|
Q2 2024 13F
Filed Aug 13, 2024
|
93 | $1.0B |
|
Q1 2024 13F
Filed May 14, 2024
|
84 | $1.1B |
|
Q4 2023 13F
Filed Feb 13, 2024
|
85 | $1.0B |
|
Q3 2023 13F
Filed Nov 9, 2023
|
85 | $927.5M |
|
Q2 2023 13F
Filed Aug 11, 2023
|
83 | $948.7M |
|
Q1 2023 13F
Filed May 12, 2023
|
88 | $910.9M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
93 | $958.5M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
90 | $955.0M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
86 | $880.2M |
|
Q1 2022 13F
Filed May 13, 2022
|
89 | $1.0B |
|
Q4 2021 13F
Filed Feb 11, 2022
|
92 | $1.5B |
|
Q3 2021 13F
Filed Nov 12, 2021
|
92 | $1.4B |
31 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MDT MEDTRONIC PLC | $48.7M | 4.86% |
| 2 | LLY LILLY ELI & CO | $45.5M | 4.54% |
| 3 | BSX BOSTON SCIENTIFIC CORP | $43.4M | 4.33% |
| 4 | VRTX VERTEX PHARMACEUTICALS INC | $38.7M | 3.86% |
| 5 | REGN REGENERON PHARMACEUTICALS | $34.3M | 3.42% |
| 6 | HCA HCA HEALTHCARE INC | $29.5M | 2.95% |
| 7 | UNH UNITED HEALTH GROUP INC | $28.4M | 2.84% |
| 8 | BMRN BIOMARIN PHARMACEUTICAL INC | $27.2M | 2.72% |
| 9 | SWAV SHOCKWAVE MEDICAL INC | $26.7M | 2.67% |
| 10 | THC TENET HEALTHCARE CORP | $26.6M | 2.65% |
| 11 | ABBV ABBVIE INC | $25.9M | 2.59% |
| 12 | ABT ABBOTT LABS | $22.6M | 2.25% |
| 13 | COO COOPER COS INC | $22.1M | 2.21% |
| 14 | ISRG INTUITIVE SURGICAL INC | $21.4M | 2.14% |
| 15 | MCK MCKESSON CORP | $21.3M | 2.13% |
| 16 | GILD GILEAD SCIENCES INC | $21.0M | 2.1% |
| 17 | COR CENCORA INC | $19.7M | 1.97% |
| 18 | DHR DANAHER CORPORATION | $18.0M | 1.8% |
| 19 | HUM HUMANA INC | $17.9M | 1.79% |
| 20 | TMO THERMO FISHER SCIENTIFIC INC | $17.8M | 1.78% |
Values as reported on the Q4 2023 Form 13F. Every position is in the holdings table below.